European equities traded in the US as American depositary receipts were trending moderately higher late Thursday morning, rising 0.62% to 1,426.64 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by oil and gas company Eni (E), which rose 2.4% and then biopharmaceutical firm DBV Technologies (DBVT), which added 2.1%. They were followed by petroleum refiner Equinor (EQNR) and electronics company Philips (PHG), which were up 1.8% and 1.7%, respectively.
The decliners from continental Europe were led by biopharmaceutical companies Cellectis (CLLS) and Genfit (GNFT), which fell 2.5% and 2%, respectively. They were followed by biopharmaceutical company Grifols (GRFS) and medical device maker EDAP TMS (EDAP), which were down 1.5% and 1.3%, respectively.
From the UK and Ireland, the gainers were led by software firm Endava (DAVA) and biopharmaceutical firm Akari Therapeutics (AKTX), which climbed 8.1% and 3.9%, respectively. Biopharmaceutical firm NuCana (NCNA) was up 2.7% and telecommunications operator Vodafone Group (VOD) added 2.1%.
The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB), which fell 2.9%, followed by biopharmaceutical company Verona Pharma (VRNA) and construction materials supplier CRH (CRH), which were both down 2.2%. Biopharmaceutical firm Mereo BioPharma (MREO) was off 1.8%.
Comments